Title: Phase 1/2 study of spevatamig (PT886) in combination with gemcitabine plus nab-paclitaxel (GnP) in frontline (1L) treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC) Session: ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

National Safety Council report shows progress in safety cultures, gaps in risk reduction and innovationWASHINGTON, Dec. 15, ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

The Disney+ video streaming service is finally available on Quest. While better late than never, it’s actually missing out on ...

Objective This study aimed to examine whether biomarker tests—finger-prick, skin-prick and offline fractional exhaled nitric oxide (FeNO)—are acceptable and feasible as a guide to treatment decisions, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump administration to ensure its prescription medicines are both accessible and ...

Consistent High Ranking Demonstrates Exceptional Value of Forward Enterprise in Delivering Operational Confidence Through ...

Led by Isaac Bruns' 29 points, the South Dakota Coyotes defeated the Prairie View A&M Panthers 97-85 on Saturday.

Inflammatory bowel diseases (IBD), comprising Crohn’s disease and ulcerative colitis, are chronic, inflammatory, immune mediated, relapsing-remitting conditions of the gastrointestinal tract with ...